149 results on '"Gupta, Rajan T"'
Search Results
2. PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI
3. Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA?
4. Interpretation of Prostate Magnetic Resonance Imaging Using Prostate Imaging and Data Reporting System Version 2.1
5. Evaluation of Recurrent Disease after Radiation Therapy for Patients Considering Local Salvage Therapy: Past vs. Contemporary Management
6. Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study
7. Optimization of non-endorectal prostate MR image quality using PI-QUAL: A multidisciplinary team approach
8. American College of Radiology initiatives on prostate magnetic resonance imaging quality
9. Relationship between pre-treatment body composition and clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line ipilimumab plus nivolumab
10. ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update
11. Patient‐reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy‐monitored study
12. Prostate MRI Qualification: AJR Expert Panel Narrative Review
13. ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update
14. Reconciling Discordance Between Prostate Biopsy Histology and Magnetic Resonance Imaging Suspicion – Implementation of a Quality Improvement Protocol of Imaging Re-review and Reverse-fusion Target Analysis
15. Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
16. Automated versus manual analysis of body composition measures on computed tomography in patients with bladder cancer
17. Guest Editorial for: “Diagnostic Efficiency of Diffusion Sequences and a Clinical Nomogram for Detecting Lymph Node Metastases From Rectal Cancer”
18. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus
19. Optimizing Multiparametric Magnetic Resonance Imaging for a Focal Therapy Practice: Quality Improvement
20. Utility of a Rule-Based Algorithm in the Assessment of Standardized Reporting in PI-RADS
21. Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement
22. Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab.
23. ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update
24. ACR Appropriateness Criteria® Newly Diagnosed Palpable Scrotal Abnormality
25. A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)
26. The SCARD Fellowship Policy and the Abdominal Imaging Fellowship: A Follow-up Survey After the First Year
27. ACR Appropriateness Criteria® Adrenal Mass Evaluation: 2021 Update
28. Contributors
29. Abdominal Trauma
30. Artificial Intelligence–assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation
31. Past, present, and future of abdominal radiology fellowship recruitment
32. Intravascular Ultrasound-Guided Transvenous Biopsy of Abdominal and Pelvic Targets Difficult to Access by Percutaneous Needle Biopsy: Technique and Initial Clinical Experience
33. Implementation of a Radiology Utilization Dashboard Yields Significant Cost Savings in a Large Primary Care Network
34. Pericardial Adipose Tissue Volume and Left Ventricular Assist Device-Associated Outcomes
35. PROSPER: Phase III RandOmized Study Comparing PERioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).
36. ACR Appropriateness Criteria® Renal Failure
37. Multimodality Approach to Detection and Characterization of Hepatic Hemangiomas
38. Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer
39. Can procedure time for paracentesis be optimized based on bottle selection?
40. Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes
41. LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types
42. Editorial Comment on “Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy”
43. PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma
44. ACR Appropriateness Criteria® Indeterminate Renal Mass
45. How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?
46. Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network
47. Assessments of frailty in bladder cancer
48. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel
49. PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).
50. Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.